Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Stauder

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Annals of Hematology|February 4, 2014
The G8 screening tool detects relevant geriatric impairments and predicts survival in elderly patients with a haematological malignancyMarije E Hamaker, M Mitrovic, R Stauder
Leukemia & Lymphoma|April 7, 2016
Clinical judgement and geriatric assessment for predicting prognosis and chemotherapy completion in older patients with a hematological malignancyM E Hamaker, J Augschoell, R Stauder
Blood|May 15, 1995
CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factorR Stauder, W Eisterer, J Thaler, et al.
Leukemia Research|January 21, 2014
The relevance of a geriatric assessment for elderly patients with a haematological malignancy--a systematic reviewM E Hamaker, M C Prins, R Stauder
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 25, 2014
On-going clinical trials for elderly patients with a hematological malignancy: are we addressing the right end points?M E Hamaker, R Stauder, B C van Munster
Critical Reviews in Oncology/Hematology|June 13, 2009
Six independent domains are defined by geriatric assessment in elderly cancer patientsR Stauder, K Moser, B Holzner, et al.
Annals of Hematology|July 29, 2018
Fatigue at baseline is associated with geriatric impairments and represents an adverse prognostic factor in older patients with a hematological malignancyF Hofer, K A Koinig, L Nagl, et al.
British Journal of Haematology|June 1, 1996
An aggressive subtype of B-CLL is characterized by strong CD44 expression and lack of CD11cW Eistere, W Hilbe, R Stauder, et al.
Journal of Hematotherapy & Stem Cell Research|February 16, 2002
Blood levels of angiogenin and vascular endothelial growth factor are elevated in myelodysplastic syndromes and in acute myeloid leukemiaB Brunner, E Gunsilius, P Schumacher, et al.
Leukemia & Lymphoma|October 26, 2020
Azacitidine is removed effectively by hemodialysisA G E Beer, E Laille, H Neuwirt, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Annals of Hematology|February 4, 2014
The G8 screening tool detects relevant geriatric impairments and predicts survival in elderly patients with a haematological malignancyMarije E Hamaker, M Mitrovic, R Stauder
Leukemia & Lymphoma|April 7, 2016
Clinical judgement and geriatric assessment for predicting prognosis and chemotherapy completion in older patients with a hematological malignancyM E Hamaker, J Augschoell, R Stauder
Blood|May 15, 1995
CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factorR Stauder, W Eisterer, J Thaler, et al.
Leukemia Research|January 21, 2014
The relevance of a geriatric assessment for elderly patients with a haematological malignancy--a systematic reviewM E Hamaker, M C Prins, R Stauder
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 25, 2014
On-going clinical trials for elderly patients with a hematological malignancy: are we addressing the right end points?M E Hamaker, R Stauder, B C van Munster
Critical Reviews in Oncology/Hematology|June 13, 2009
Six independent domains are defined by geriatric assessment in elderly cancer patientsR Stauder, K Moser, B Holzner, et al.
Annals of Hematology|July 29, 2018
Fatigue at baseline is associated with geriatric impairments and represents an adverse prognostic factor in older patients with a hematological malignancyF Hofer, K A Koinig, L Nagl, et al.
British Journal of Haematology|June 1, 1996
An aggressive subtype of B-CLL is characterized by strong CD44 expression and lack of CD11cW Eistere, W Hilbe, R Stauder, et al.
Journal of Hematotherapy & Stem Cell Research|February 16, 2002
Blood levels of angiogenin and vascular endothelial growth factor are elevated in myelodysplastic syndromes and in acute myeloid leukemiaB Brunner, E Gunsilius, P Schumacher, et al.
Leukemia & Lymphoma|October 26, 2020
Azacitidine is removed effectively by hemodialysisA G E Beer, E Laille, H Neuwirt, et al.
Pageof 6